Fourteen patients with Alzheimer's disease were evaluated by psychometric testing, fluorodeoxyglucose positron emission tomography (PET), and EEG. They were divided into two groups according to the EEG findings. Group A (seven patients) had normal alpha backgrounds and group B (seven patients) had decreased alpha backgrounds. Group A had significantly higher WAIS Performance IQ scores (p = 0.005) than group B. Group A also had higher Weschler Memory Scale scores (p = 0.047) and parietal glucose metabolic rates (p = 0.038) than group B, but these differences are not statistically significant given the multiple comparisons made between the two groups. Relative intactness of parietal lobe function, as measured by psychometric testing and PET, appears to correlate with preservation of EEG alpha background. The EEG may be useful in assessing regional cortical involvement or the clinical stage in Alzheimer's disease.
Age-related changes in the response of rabbit papillary muscles to isoproterenol
and calcium were studied. Newborn rabbit papillary muscles were not only less sensitive
to the inotropic effect of isoproterenol and calcium, but also produced significantly less
maximal inotropic tension to these agents in comparison to the adult. The decreased
response of newborn papillary muscle to isoproterenol appears to be due to a combination
of (a) decreased ability of papillary muscle to respond to calcium and (b) immaturity of
isoproterenol-sensitive contractile mechanism. Differences in myocardial norepinephrine
content do not appear to play an important role in the age-related difference in the response
to isoproterenol and calcium.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.